FOLFOX-HAIC
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for FOLFOX-HAIC, covering 2021-07-14 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus [Phase 2]